CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
|
12 Months Ended |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Revenue: |
|
|
| Collaboration revenue |
$ 22,935,000
|
$ 2,915,000
|
| Total revenue |
22,935,000
|
2,915,000
|
| Operating expenses: |
|
|
| Research and development |
64,855,000
|
73,981,000
|
| General and administrative |
27,629,000
|
19,852,000
|
| Total operating expenses |
92,484,000
|
93,833,000
|
| Loss from operations |
(69,549,000)
|
(90,918,000)
|
| Other income (expense): |
|
|
| Gain on disposition |
33,286,000
|
|
| Other income |
1,780,000
|
906,000
|
| Interest income |
22,000
|
253,000
|
| Interest expense |
(2,696,000)
|
(1,906,000)
|
| Total other income (expense), net |
32,392,000
|
(747,000)
|
| Net loss |
(37,157,000)
|
(91,665,000)
|
| Cumulative dividends on redeemable convertible preferred stock |
|
(10,831,000)
|
| Net loss attributable to common stockholders |
$ (37,157,000)
|
$ (102,496,000)
|
| Net loss per share attributable to common stockholders, basic and diluted |
$ (1.70)
|
$ (16.18)
|
| Weighted average common shares outstanding, basic and diluted |
21,794,546
|
6,332,841
|
| Comprehensive loss: |
|
|
| Net loss |
$ (37,157,000)
|
$ (91,665,000)
|
| Other comprehensive loss: |
|
|
| Unrealized loss on investments, net of tax of $0 |
|
(43,000)
|
| Total other comprehensive loss |
(0)
|
(43,000)
|
| Comprehensive loss |
$ (37,157,000)
|
$ (91,708,000)
|